Cardinal Health Receives Patent For Mammalian Cell Genetic Engineering Technology
08-Apr-2005 -
Cardinal Health announced it has been granted its first patent for an innovative technology that will help in the mass production of biopharmaceuticals. The company received U.S. Patent No. 6,852,510, entitled "Host Cells Containing Multiple Integrating Vectors", for its gene product expression ...
Alzheimer's disease
antibodies
arthritis
+10